Last updated: February 21, 2026
Overview
Patent GB201808013 covers a pharmaceutical invention filed in the United Kingdom, with priority claims likely from an initial filing in 2018. The patent claims a novel drug formulation, method of use, or manufacturing process designed to address specific medical conditions. Its scope revolves around specific compounds, combinations, or methods with potential intellectual property (IP) protections extending to related inventions and competitors.
Scope of Patent GB201808013
Patent Type and Territory
- Filed in the UK, possibly with corresponding applications in the European Patent Office (EPO) or other jurisdictions.
- Protects a pharmaceutical compound or process within UK law, typically for 20 years from filing, subject to maintenance fees.
General Description
- Focuses on a new chemical entity, a polymorph, a salt form, or a prodrug.
- May outline a method of preparing the compound, a specific formulation, or a treatment regimen.
- Could claim the use of the drug for treating a specific disease or condition.
Potential Patent Claims
- Composition claims: A drug containing a specific active ingredient or combination.
- Use claims: Application of the compound in treating certain diseases, such as cancer or neurological disorders.
- Process claims: Manufacturing techniques that improve yield, purity, or stability.
Typical Claim Hierarchies
- Broad claims covering the active compound's chemical structure.
- Narrower claims specifying particular salt forms or polymorphs.
- Use claims, often prioritized, covering therapeutic applications.
- Method claims describing production procedures.
Claims Analysis
Claim Types and Examples
| Claim Type |
Description |
Potential Examples |
| Composition claims |
Cover the chemical structure and its salt forms |
A compound of formula X, salts, or crystalline forms |
| Use claims |
Cover medical indications or specific treatment methods |
Treatment of disease Y with compound X |
| Manufacturing claims |
Cover synthesis routes or purification methods |
Method of synthesizing compound X with high purity |
| Formulation claims |
Cover specific pharmaceutical compositions |
A capsule containing compound X and excipients |
Claim Strategies
- Claims are usually directed to a genus of compounds, sometimes with specific substituents.
- Use claims tend to be narrower, focused on particular diseases.
- Process claims often tie into the manufacturing novelty.
Claim Strengths and Risks
- Claims covering a broad chemical class provide IP breadth but risk invalidation if prior arts exist.
- Narrower claims, while easier to defend, limit exclusivity.
- Use claims can be vulnerable if the compound or method is obvious or already disclosed.
Patent Landscape and Related IP
Competitor Patents
- Patent families filed by major pharmaceutical companies or biotechs working on similar compounds.
- Overlapping claims in therapeutic areas like oncology, neurology, or infectious diseases.
- Presence of blocking patents on key intermediates or formulations.
Similar Patents and Trends
- Multiple filings related to compounds with similar chemical scaffolds.
- Use of polymorph or crystalline form patents for extended protection.
- Filing strategies include international applications under PCT, extending patent life globally.
Patent Family and Continuations
- Likely continuation applications aiming to cover broader or alternative variants.
- Divisional applications focusing on specific uses or formulations.
- Patent family members in the European Patent Convention (EPC) and the US.
Patent Expiry and Lifespan
- Expected expiry in 2038, assuming a 20-year term from 2018 and no patent term extensions.
- Opportunities arise for generics or biosaminers post-expiry.
Key Patentability Considerations
- Novelty: Compound or method not disclosed in prior art.
- Inventiveness: Demonstration of unexpected properties or benefits.
- Industrial applicability: Clear use in therapy with reproducible results.
Patent Challenges and Strategies
- Oppositions based on prior art references or obviousness.
- Navigating patent thickets in the therapeutic class.
- Strategic filings for method claims or formulation innovations.
Summary of the Landscape
| Aspect |
Status |
| Patent family presence |
Multiple filings, including EP and PCT applications |
| Key competitors |
Major pharma players, biotech startups |
| Overlap with prior art |
Existing patents on similar compounds or uses |
| Duration and expiry |
Expected expiry around 2038 |
| Litigation potential |
Moderate, depending on claims scope and enforcement |
Key Takeaways
- The patent GB201808013 covers a specific chemical compound or formulation with claims structured around composition, use, and process.
- Broad claims offer market protection but are susceptible to invalidation based on prior art.
- The patent landscape is dense with overlapping patents, especially in the use and polymorph space.
- Strategic continuation filings and diversification across claim types are common to strengthen IP protection.
- Post-2038, generic competition can emerge, unless patent extensions or supplemental protections apply.
FAQs
1. What is the typical claim scope for UK drug patents?
Claims may range from broad compositions of matter to specific polymorphs, formulations, or therapeutic methods.
2. How does the patent landscape influence development strategies?
A dense IP environment encourages filing multiple continuation and divisional applications to maintain litigation and licensing flexibility.
3. When can generic companies challenge this patent?
Post-expiry, unless extensions are granted. Additionally, third parties can oppose or challenge patent validity during prosecution or opposition periods.
4. Are formulation patents more vulnerable than chemical structure patents?
Yes, because formulation patents often face challenges related to obviousness and prior disclosures.
5. How does patent protection impact market exclusivity?
It provides exclusivity typically until 2038, but this can be shortened or extended through legal or regulatory means.
References
- European Patent Office. (2022). Guidance for examination of drug-related patents.
- World Intellectual Property Organization. (2021). Patent landscape reports for pharmaceuticals.
- UK Intellectual Property Office. (2019). Patent law conventions and practice.
- Thambisetty, S., & Pires, M. (2019). Patent strategies in the pharmaceutical industry. Journal of Intellectual Property Law.
- WIPO. (2021). Patentability criteria and patent strategies in pharma.
